| NCT ID | NCT06038227 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Intuitive Surgical |
| Condition | Lung Cancer |
| Study Type | OBSERVATIONAL |
| Enrollment | 512 participants |
| Start Date | 2023-07-15 |
| Primary Completion | 2027-12-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 512 participants in total. It began in 2023-07-15 with a primary completion date of 2027-12-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
To compare outcomes of minimally invasive surgical techniques for the treatment of early-stage non-small cell lung cancer.
Eligibility Criteria
Inclusion Criteria: * Patient diagnosed with clinical stage IA1-2 non-small cell lung cancer at time of procedure * Patient scheduled to undergo minimally invasive surgery for NSCLC with either da Vinci robotic assisted surgery or VATs * Aged ≥ 18 years * Must be willing and able to comply with study requirements * Must indicate their understanding of the study and willingness to participate by signing an appropriate informed consent form Exclusion Criteria: * Patients with clinical stage IA3, II, III, and IV lung cancer * Patient receiving a lobectomy/segmentectomy as an emergency procedure * Patients receiving a lobectomy/segmentectomy for metastatic cancer * Patients scheduled to receive a bilobectomy or sleeve-lobectomy * Mental incapacity to understand or consent to study procedures * Anticipated difficulty for patient to comply with protocol requirements * Unable to comply with the follow up schedule * Pregnant or are planning to become pregnant during the study * Life expectancy \< 12 months
Contact & Investigator
Tom Routledge
PRINCIPAL INVESTIGATOR
Guy's St Thomas' NHS Foundation Trust, UK
Frequently Asked Questions
Who can join the NCT06038227 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Lung Cancer. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06038227 currently recruiting?
Yes, NCT06038227 is actively recruiting participants. Contact the research team at Marie.Allouis@intusurg.com for enrollment information.
Where is the NCT06038227 trial being conducted?
This trial is being conducted at Copenhagen, Denmark, Marseille, France, Rouen, France, Toulouse, France and 8 additional locations.
Who is sponsoring the NCT06038227 clinical trial?
NCT06038227 is sponsored by Intuitive Surgical. The principal investigator is Tom Routledge at Guy's St Thomas' NHS Foundation Trust, UK. The trial plans to enroll 512 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.